• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 213/60 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 213/60

Total number of patents in this class: 100

10-year publication summary

1
4
3
8
4
2
6
2
8
2
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Syngenta Participations AG
1730
4
Bayer Pharma AG
1048
4
BeiGene, Ltd.
292
4
BASF SE
21098
3
Bayer Cropscience AG
1983
3
The Brigham and Women's Hospital, Inc.
2227
3
H. Lundbeck A/S
1237
3
Bristol-myers Squibb Company
4826
2
Merck Sharp & Dohme Corp.
2189
2
Battelle Memorial Institute
2513
2
Beijing Yiling Bioengineering Co., Ltd.
3
2
Kyoto University
2857
2
Medshine Discovery Inc.
595
2
Nihon Medi-physics Co., Ltd.
175
2
sanofi-aventis
346
2
Merck Sharp & Dohme LLC
3732
2
Soter Biopharma Pte. Ltd.
11
2
F. Hoffmann-La Roche AG
7937
1
The Regents of the University of California
20303
1
Genentech, Inc.
4016
1
Other owners 53